Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jun;106(2):452–458. doi: 10.1111/j.1476-5381.1992.tb14355.x

Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors.

S J Trout 1, Z L Kruk 1
PMCID: PMC1907521  PMID: 1393270

Abstract

1. Dopamine efflux following single pulse or train of pulse stimulations was measured in slices of rat caudate putamen, nucleus accumbens and tuberculum olfactorium, using fast cyclic voltammetry at a carbon fibre microelectrode; 1, 5, 10, 20 or 50 pulses were applied at each location at frequencies varying from 10 Hz to 500 Hz. 2. There are significant differences in the ability of the different regions to increase dopamine efflux following single or repeated electrical stimulation. 3. Highest release in response to a single pulse is observed in the caudate putamen (approximately 250 nM dopamine), but the ratio of the peak dopamine overflow following a train of 20 pulses (50 Hz) when compared to a single pulse is rarely greater than three. 4. Release following single pulse stimulation in the nucleus accumbens (approximately 185 nM dopamine) is often slightly less than in the caudate putamen, but the ratio of peak release when trains of 20 pulses (50 Hz) are compared to single pulse stimulation has been as great as seven fold. 5. The tuberculum olfactorium releases the least dopamine of the three regions following a single pulse stimulation (approximately 40 nM dopamine), but the ratio of peak dopamine release following trains of 20 pulses (50 Hz) when compared to single pulse can result in a value approaching 20. 6. When 20 pulses are applied to the caudate putamen at frequencies ranging from 10 to 500 Hz, the peak efflux is essentially the same (frequency/release profile is flat), with the maximum increase only 140% that of a single pulse.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong-James M., Millar J. Carbon fibre microelectrodes. J Neurosci Methods. 1979 Oct;1(3):279–287. doi: 10.1016/0165-0270(79)90039-6. [DOI] [PubMed] [Google Scholar]
  2. Bartfai T., Iverfeldt K., Fisone G., Serfözö P. Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol. 1988;28:285–310. doi: 10.1146/annurev.pa.28.040188.001441. [DOI] [PubMed] [Google Scholar]
  3. Bull D. R., Palij P., Sheehan M. J., Millar J., Stamford J. A., Kruk Z. L., Humphrey P. P. Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. J Neurosci Methods. 1990 Apr;32(1):37–44. doi: 10.1016/0165-0270(90)90069-r. [DOI] [PubMed] [Google Scholar]
  4. Bull D. R., Sheehan M. J. Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):260–265. doi: 10.1007/BF00251124. [DOI] [PubMed] [Google Scholar]
  5. Cejna M., Agneter E., Drobny H., Valenta B., Singer E. A. Pulse-to-pulse modulation of transmitter release in the central nervous system. Basic and pharmacological aspects. Ann N Y Acad Sci. 1990;604:211–221. doi: 10.1111/j.1749-6632.1990.tb31995.x. [DOI] [PubMed] [Google Scholar]
  6. Chiodo L. A., Bunney B. S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci. 1983 Aug;3(8):1607–1619. doi: 10.1523/JNEUROSCI.03-08-01607.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chiodo L. A. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci Biobehav Rev. 1988 Spring;12(1):49–91. doi: 10.1016/s0149-7634(88)80073-3. [DOI] [PubMed] [Google Scholar]
  8. Dwoskin L. P., Zahniser N. R. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors. J Pharmacol Exp Ther. 1986 Nov;239(2):442–453. [PubMed] [Google Scholar]
  9. Freeman A. S., Bunney B. S. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res. 1987 Mar 3;405(1):46–55. doi: 10.1016/0006-8993(87)90988-7. [DOI] [PubMed] [Google Scholar]
  10. Freeman A. S., Meltzer L. T., Bunney B. S. Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci. 1985 May 20;36(20):1983–1994. doi: 10.1016/0024-3205(85)90448-5. [DOI] [PubMed] [Google Scholar]
  11. Grace A. A., Bunney B. S. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 1984 Nov;4(11):2866–2876. doi: 10.1523/JNEUROSCI.04-11-02866.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grace A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 1991;41(1):1–24. doi: 10.1016/0306-4522(91)90196-u. [DOI] [PubMed] [Google Scholar]
  13. Hoffmann I. S., Cubeddu L. X. Rate and duration of stimulation determine presynaptic effects of haloperidol on dopaminergic neurons. J Neurochem. 1982 Aug;39(2):585–588. doi: 10.1111/j.1471-4159.1982.tb03987.x. [DOI] [PubMed] [Google Scholar]
  14. Limberger N., Trout S. J., Kruk Z. L., Starke K. "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):623–629. doi: 10.1007/BF00174745. [DOI] [PubMed] [Google Scholar]
  15. Millar J., Stamford J. A., Kruk Z. L., Wightman R. M. Electrochemical, pharmacological and electrophysiological evidence of rapid dopamine release and removal in the rat caudate nucleus following electrical stimulation of the median forebrain bundle. Eur J Pharmacol. 1985 Mar 12;109(3):341–348. doi: 10.1016/0014-2999(85)90394-2. [DOI] [PubMed] [Google Scholar]
  16. O'Connor J. J., Kruk Z. L. Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices. J Neurosci Methods. 1991 Jun;38(1):25–33. doi: 10.1016/0165-0270(91)90150-x. [DOI] [PubMed] [Google Scholar]
  17. Palij P., Bull D. R., Sheehan M. J., Millar J., Stamford J., Kruk Z. L., Humphrey P. P. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res. 1990 Feb 12;509(1):172–174. doi: 10.1016/0006-8993(90)90329-a. [DOI] [PubMed] [Google Scholar]
  18. Richards C. D., Tegg W. J. A superfusion chamber suitable for maintaining mammalian brain tissue slices for electrical recording [proceedings]. Br J Pharmacol. 1977 Mar;59(3):526P–526P. [PMC free article] [PubMed] [Google Scholar]
  19. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990 Sep 13;347(6289):146–151. doi: 10.1038/347146a0. [DOI] [PubMed] [Google Scholar]
  20. Stamford J. A., Kruk Z. L., Millar J. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Br J Pharmacol. 1988 Jul;94(3):924–932. doi: 10.1111/j.1476-5381.1988.tb11605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stamford J. A., Kruk Z. L., Millar J. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data. Eur J Pharmacol. 1987 Jul 23;139(3):363–364. doi: 10.1016/0014-2999(87)90598-x. [DOI] [PubMed] [Google Scholar]
  22. Stamford J. A., Kruk Z. L., Millar J. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. Br J Pharmacol. 1991 Jan;102(1):45–50. doi: 10.1111/j.1476-5381.1991.tb12130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989 Jul;69(3):864–989. doi: 10.1152/physrev.1989.69.3.864. [DOI] [PubMed] [Google Scholar]
  24. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl. 1971;367:1–48. doi: 10.1111/j.1365-201x.1971.tb10998.x. [DOI] [PubMed] [Google Scholar]
  25. Valenta B., Drobny H., Singer E. A. Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition. J Pharmacol Exp Ther. 1988 Jun;245(3):944–949. [PubMed] [Google Scholar]
  26. Versteeg D. H., Van Der Gugten J., De Jong W., Palkovits M. Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 1976 Sep 3;113(3):563–574. doi: 10.1016/0006-8993(76)90057-3. [DOI] [PubMed] [Google Scholar]
  27. White F. J., Wang R. Y. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci. 1983 Feb 28;32(9):983–993. doi: 10.1016/0024-3205(83)90929-3. [DOI] [PubMed] [Google Scholar]
  28. White F. J., Wang R. Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science. 1983 Sep 9;221(4615):1054–1057. doi: 10.1126/science.6136093. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES